18 October 2024 - The outcomes from the September 2024 PBAC intracycle meeting are now available.

The PBAC recommended the following medicines:

• Fruquinitib (Fruzaqla) - new medicine
• Osilodrostat phosphate (Isturisa) - new medicine

Read PBAC outcomes